Cite
MLA Citation
M.C. Genovese et al.. “THU0133 Results from A Phase 2A, Randomized, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group Study of Jnj-40346527, an Oral CSF-1R Inhibitor, in Patients with Active Rheumatoid Arthritis despite Disease-Modifying Antirheumatic Drug Therapy.” Annals of the rheumatic diseases, vol. 73, 2014, pp. 224–225. http://access.bl.uk/ark:/81055/vdc_100135145910.0x000059